Petros Grivas, Clinical Director of the GU Cancer Program at the University of Washington, shared Vivek Subbiah’s, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, post on X, adding:
“I agree with Vivek Subbiah about Chadi Nabhan.
Chadi, will our discussion about data include the resolution about baklava issue?
Can’t wait to see you in Chicago!”
Quoting Vivek Subbiah’s post:
“ASCO Annual meeting ASCO26 is basically here.
Three weeks out, and the incredible Chadi Nabhan host of Healthcare unfiltered podcast is already setting the pace with Paradigms in Practice – PIP – real – time ASCO data, no didactics, all live cross‑tumor discussions.”
Thrilled to join this group at ASCO26.”
Other articles featuring Petros Grivas and Vivek Subbiah on OncoDaily.